David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$453M |
| 2 |
Oracle
ORCL
|
+$431M |
| 3 |
Apple
AAPL
|
+$376M |
| 4 |
SLB Ltd
SLB
|
+$353M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$746M |
| 2 |
AET
Aetna Inc
AET
|
+$378M |
| 3 |
NVIDIA
NVDA
|
+$348M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$307M |
| 5 |
AT&T
T
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.42% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 11.33% |
| 4 | Financials | 7.58% |
| 5 | Communication Services | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
WaFd
WAFD
$2.68B
| $1.79M | ﹤0.01% |
67,149
-113,067
| -63% | -$3.18M |
|
|
INSY
2202
DELISTED
Insys Therapeutics, Inc.
INSY
| $1.79M | ﹤0.01% |
512,444
+314,264
| +159% | +$2.18M |
|
2203
KBR
KBR
$4.78B
| $1.79M | ﹤0.01% |
+118,000
| New | +$2.21M |
|
|
HA
2204
PUT
DELISTED
Hawaiian Holdings, Inc.
HA
| $1.79M | ﹤0.01% |
+67,800
| New | +$2.3M |
|
2205
SiriusPoint
SPNT
$2.79B
| $1.79M | ﹤0.01% |
+185,633
| New | +$1.99M |
|
2206
CALL
Fortinet
FTNT
$116B
| $1.79M | ﹤0.01% |
127,000
+6,500
| +5% | +$99K |
|
|
NBR.PRA
2207
DELISTED
Nabors Industries Ltd. 6.00% Mandatory Convertible Preferred Shares, Series A
NBR.PRA
| $1.79M | ﹤0.01% |
+100,000
| New | +$3.3M |
|
2208
PUT
Colgate-Palmolive
CL
$73.4B
| $1.79M | ﹤0.01% |
30,000
-10,000
| -25% | -$626K |
|
2209
Lexicon Pharmaceuticals
LXRX
$1.03B
| $1.78M | ﹤0.01% |
268,476
+173,096
| +181% | +$1.4M |
|
2210
Texas Roadhouse
TXRH
$13.4B
| $1.78M | ﹤0.01% |
29,857
+25,860
| +647% | +$1.66M |
|
2211
Valmont Industries
VMI
$9.21B
| $1.78M | ﹤0.01% |
16,051
-7,180
| -31% | -$895K |
|
|
MYND
2212
Mynd.ai
MYND
$19.5M
| $1.78M | ﹤0.01% |
30,455
+18,808
| +161% | +$2.44M |
|
2213
Harmonic Inc
HLIT
$1.36B
| $1.78M | ﹤0.01% |
376,366
+69,000
| +22% | +$376K |
|
2214
Franklin Electric
FELE
$4.53B
| $1.77M | ﹤0.01% |
41,380
+18,744
| +83% | +$812K |
|
|
UN
2215
DELISTED
Unilever NV New York Registry Shares
UN
| $1.77M | ﹤0.01% |
+32,819
| New | +$1.79M |
|
2216
Enterprise Financial Services Corp
EFSC
$2.29B
| $1.76M | ﹤0.01% |
46,878
+216
| +0.5% | +$9.62K |
|
2217
Cerus
CERS
$552M
| $1.76M | ﹤0.01% |
347,610
-496,191
| -59% | -$2.88M |
|
|
ROCC
2218
PUT
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.76M | ﹤0.01% |
32,600
-55,600
| -63% | -$3.62M |
|
2219
Supernus Pharmaceuticals
SUPN
$2.61B
| $1.76M | ﹤0.01% |
+52,902
| New | +$2.27M |
|
|
OPB
2220
DELISTED
Opus Bank Common Stock
OPB
| $1.76M | ﹤0.01% |
89,677
-46,822
| -34% | -$998K |
|
|
LKFT
2221
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.91B
| $1.75M | ﹤0.01% |
19,093
+14,893
| +355% | +$1.51M |
|
2222
VanEck Semiconductor ETF
SMH
$65.9B
| $1.75M | ﹤0.01% |
+40,000
| New | +$1.88M |
|
|
TRQ
2223
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $1.75M | ﹤0.01% |
105,749
+10,805
| +11% | +$195K |
|
2224
CALL
EOG Resources
EOG
$76B
| $1.74M | ﹤0.01% |
20,000
| – | – |
|
2225
CALL
Universal Insurance Holdings
UVE
$1.22B
| $1.74M | ﹤0.01% |
+46,000
| New | +$2M |
|
Similar funds
David Shaw's Q4 2018 Portfolio in Review
As of Q4 2018, David Shaw held 4,217 positions worth $72.6B, down 13% from $83.2B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
David Shaw deployed $3.99B of net new capital in Q4 2018, opening 541 new positions and adding to 1,544 existing holdings. Its largest new stake was Alibaba: 3,066,336 shares worth $420M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $746M trimmed.
- David Shaw's largest Q4 2018 buy was Alibaba: 3,066,336 shares worth $420M.
- David Shaw added most to Oracle in Q4 2018, an estimated $431M increase.
- David Shaw's biggest Q4 2018 reduction was Amazon, cutting an estimated $746M.
- David Shaw fully exited Aetna Inc in Q4 2018, selling an estimated $378M.
- David Shaw's ten largest holdings make up 8.9% of its $72.6B portfolio in Q4 2018.
- David Shaw opened 541 new positions and closed 497 in Q4 2018.
- David Shaw's portfolio value fell 13% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.